title: Repeated superovulation using a simplified FSH/eCG treatment for in vivo embryo production in sheep.
abstract: This study investigated the efficacy of a simplified repeated superovulation treatment (eCG plus FSH in a single dose, rather than the usual protocol of six decreasing doses of FSH) in the in vivo embryo production in Ojalada donor ewes during the breeding season. In vitro viability after vitrification and warming of embryos recovered from both treatments was also assessed. In addition, the study examined the effects of the concentration of anti-eCG antibodies before each eCG/FSH treatment on in vivo embryo production. Thirty-eight females at the end of their reproductive lives were given the decreasing (n = 19) or simplified (n = 19) superovulatory treatment up to three times at intervals of ≥ 50 d. The onset of estrus was 5 h earlier (P < 0.05) among ewes that received the eCG/FSH protocol (25.2 ± 0.80 h) than it was among those that received the decreasing superovulatory treatment (30.1 ± 1.0 h), but the two treatments did not differ significantly in ovulation rates or the number and viability of embryos recovered. Both of the superovulatory protocols were significantly (P < 0.05 to P < 0.01) less effective after the first application. After three superovulatory treatments, the average number of viable embryos per ewe was 14.1 ± 2.3 and 13.7 ± 2.5 in the decreasing and simplified protocols, respectively. High anti-eCG antibody concentrations just before the superovulatory treatment with eCG/FSH were associated with a significant decrease (P < 0.05) in the rates of fertilization, viability, and freezability, especially in the second and third recoveries. Repeated superovulatory treatments with eCG/FSH can provide an efficient means of producing high quality embryos in the ewes of endangered breeds at the end of their reproductive lives, although further studies are needed to characterize the response associated with high concentrations of anti-eCG antibodies.
authors.affiliation: Instituto de Investigación de Ciencias Ambientales de Aragón (IUCA), Universidad de Zaragoza, Zaragoza, Spain. forcada@unizar.es
authors.forename: F
authors.initials: F
authors.lastname: Forcada
authors.forename: M
authors.initials: M
authors.lastname: Ait Amer-Meziane
authors.forename: J A
authors.initials: JA
authors.lastname: Abecia
authors.forename: M C
authors.initials: MC
authors.lastname: Maurel
authors.forename: J A
authors.initials: JA
authors.lastname: Cebrián-Pérez
authors.forename: T
authors.initials: T
authors.lastname: Muiño-Blanco
authors.forename: B
authors.initials: B
authors.lastname: Asenjo
authors.forename: M I
authors.initials: MI
authors.lastname: Vázquez
authors.forename: A
authors.initials: A
authors.lastname: Casao
mesh_terms: D000818:Animals; D001755:Blastocyst; D006063:Chorionic Gonadotropin / Q000008:administration & dosage / Q000494:pharmacology*; D015925:Cryopreservation / Q000662:veterinary; D046149:Embryo Culture Techniques; D005260:Female; D005640:Follicle Stimulating Hormone / Q000008:administration & dosage / Q000494:pharmacology*; D006728:Hormones / Q000008:administration & dosage / Q000494:pharmacology*; D006736:Horses; D006861:Hydrogen Peroxide / Q000378:metabolism; D011374:Progesterone / Q000097:blood; D027724:Reproductive Techniques, Assisted / Q000662:veterinary; D012756:Sheep / Q000196:embryology*; D013480:Superovulation / Q000187:drug effects*
chemical_list: D006063:Chorionic Gonadotropin; D006728:Hormones; D011374:Progesterone; D005640:Follicle Stimulating Hormone; D006861:Hydrogen Peroxide